b Dried blood spots (DBS) are useful for molecular assays but are prone to false positives from cross-contamination. In our malaria DBS assay, cross-contamination was encountered despite cleaning techniques suitable for HIV-1. We therefore developed a contact-free laser cutting system that effectively eliminated cross-contamination during DBS processing.
D
ried blood spots (DBS) are easily collected, stored, and transported and are suitable for many diagnostic tests (2, 3, 5, 7, 8, 12) . However, cross-contamination of molecular DBS assays is a potential problem since the sample-containing region is usually physically touched by manual or automated punching devices. Contaminating DNA and/or RNA carried over from a positive sample can result in subsequent false-positive results.
The risk of cross-contamination is related to the concentration of the nucleic acid template and has been most well studied for HIV-1 DBS. False positives are infrequent at low viral loads but increase (2.5 to 3.0%) at higher levels (5 ϫ 10 3 pol copies/punch) (10) . Cleaning between samples by repeatedly punching negativecontrol paper can eliminate most false positives, whereas bleach cleaning corrodes the cutting edge and increases the false-positive rate (10) . False positives are also more common for manual versus automated disc punching (4) . Collectively, the literature suggests that disc punching with cleaning precautions is suitable for most HIV-1 DBS.
Assays for pathogens that reach higher template concentrations than HIV-1 may be at greater risk for significant nucleic acid carryover. For instance, false-positive results for beak and feather disease virus (BFDV) were propagated into 13 samples processed after a BFDV-positive sample (1) . BVDF contamination was removed by bleach, water, and ethanol washes, followed by air drying, but such steps are laborious and poorly suited for highthroughput labs. Although a negative-control sample is usually included in each test run to control for gross contamination of common reagents, negative controls are not interspersed between every specimen. Without definitive ways to eliminate or detect cross-contamination in the routine workflow of clinical laboratories, samples with high pathogen loads processed using contactdependent methods remain at risk for false positives from crosscontamination.
Here, we adapted a Plasmodium falciparum reverse transcription (RT)-PCR assay (11) to utilize TaqMan probe chemistry and a noncompetitive internal control (IC) RNA on liquid blood and DBS. Cultured parasites were diluted into whole blood as in reference 11 at high, medium, and low parasitemias (4 ϫ 10 , and 80 parasites/ml, respectively). Liquid blood samples (50 l) were stored in NucliSens lysis buffer (bioMérieux, Marcy l'Etoile, France) (11). Total nucleic acids were extracted on an Abbott m2000sp (Abbott Molecular, Niles, IL). The noncompetitive IC RNA was synthesized in vitro using T7 RNA polymerase from an AlwNI-digested pCRII plasmid (Invitrogen, Carlsbad, CA) containing a 94-bp fragment of the Drosophila white gene (5=-CAAGCAGCCATGCAAATGTTAGCT AGTGCATCCAGTGCATGCAGGGCCGTCCTACCAACTACAA TCGAGAGAACCAAGGGGAAGTGACATAGCA-3=) and was added upon extraction. Eluates were amplified by multiplex RT-PCR using the AgPath one-step RT-PCR kit (Ambion, Grand Island, NY), P. falciparum 18S rRNA primers (9, 11), a BHQplus-labeled P. falciparum probe [5=-(6-carboxyfluorescein {FAM})-ATTTATTCAGTAATCAAATTAGGAT-3=-(black hole quencher 1) (courtesy of Abbott Molecular and Biosearch Technologies, Novato, CA)], IC primers (forward, CAAGCAGCCAT GCAAATGTT; reverse, TGCTATGTCACTTCCCCTTGGTTCT CT), and an IC probe [5=-(VIC)ATTGTAGTTGGTAGGAC-(minor groove binder/nonfluorescent quencher) (Applied Biosystems, Carlsbad, CA)]. Assay performance was comparable to that of the first-generation assay (11) , with the following values: analytical sensitivity, 20 parasites/ml; target recovery, 107% (95% confidence interval [CI], 60 to 154%); linear correlation (r 2 ϭ 0.9911, slope ϭ 1.03); minimal bias of ϩ0.143 log 10 RNA copies/ml (95% CI, Ϫ0.379 to ϩ0.367 log 10 RNA copies/ml); and no false-positive or -negative results. RNA copies were converted to parasites/ml using an m2000-specific conversion factor (3.56 mean log 10 18S rRNA copies/parasite; 95% CI, 3.51 to 3.61 log 10 ) determined by testing P. falciparum samples and RNA standards as in reference 11. Testing of paired samples on the first-and second-generation assays indicated that platform-specific conversion factors were appropriate for both assays (data not shown). Notably, there was no cross-contamination of negative liquid blood samples. To date, the second-generation assay for whole blood was used to support a clinical malaria trial with Ͼ1,000 RT-PCR samples (our unpublished data).
We next adapted the assay to DBS. Fifty-microliter aliquots were spotted onto Whatman 903 cards (GE/Whatman, Kent, United Kingdom) that were dried for 4 h and stored at Ϫ80°C with desiccant (Fisher, Pittsburgh, PA). DBS samples were processed by punching the entire spot into 2 ml lysis buffer using a manual puncher; the puncher was cleaned as described previously (10) .
Lysis buffer containing the excised DBS was agitated for 2 h at room temperature and then tested as for liquid samples. With this method, we immediately observed numerous false positives in malaria-negative DBS processed after high-parasitemia samples.
We hypothesized that preanalytical contamination can be prevented by eliminating contact with the blood-containing surfaces of the DBS. Therefore, we developed a touchless DBS laser cutting system. DBS cards were positioned above a collection tube without making contact with blood-containing portions of the card. A 10W laser cutter (Universal Laser Systems, Scottsdale, AZ) excised an 8.89-mm disc (corresponding to 27.4 l of blood), which fell into the tube below; this was the largest disc that would enter the 4-ml tubes (Simport, Beloeil, Canada) without manual manipulation.
Cross-contamination was evaluated by repeatedly testing a malaria-positive sample followed by a malaria-negative sample. Using DBS cards containing five spots of the same parasitemia, a high-, medium-, or low-parasitemia sample was processed, followed by a negative sample from a separate card. Positive/negative paired samples are shown in Table 1 . Carryover was not detected in laser-cut DBS but was detected following 7/8 high-and 2/6 medium-parasitemia samples processed by punching (Table 1 and Fig. 1 ). There were no false positives following low-parasitemia samples processed by either method. Only 2/9 false positives generated values Ն20 parasites/ml (limit of quantification for this assay). However, almost all false positives were due to carryover of Ͼ10 2 contaminating template copies/sample, a concerning level of template easily detected by most molecular assays. 
